Author:
Luo Peng,Zhang Yan-dong,He Feng,Tong Chang-jun,Liu Kai,Liu He,Zhu Shi-zhuang,Luo Jian-zhou,Yuan Bing
Abstract
AbstractExtensive evidence has explored the involvement of microRNAs (miRNAs) in osteosarcoma (OS). Limitedly, the concrete function of microRNA-18b-5p (miR-18b-5p) in OS remains unexplored and largely elusive. Here, we validated that miR-18b-5p significantly elevated in OS via analyzing the data from GEO database. The results showed that miR-18b-5p was overexpressed in human OS tissues and cell lines. The clinical evidence suggested that high level of miR-18b-5p was negatively correlated with the poor prognosis of OS. Meanwhile, miR-18b-5p upregulation facilitated the proliferation and metastasis of OS cells in vitro and in vivo. The mechanism exploration demonstrated that miR-18b-5p acted as a potential inhibitor of PHF2, a tumor suppressor gene, at post-transcriptional level. Moreover, hypoxia induced gene expression of miR-18b-5p was clarified to be transcriptionally mediated by HIF-1α. The clinicopathological analysis in samples of OS patients further supported that miR-18b-5p had a positive correlation with HIF-1α expression, and negative correlation with PHF2. Collectively, the present study uncovered a new molecular mechanism of OS tumorigenesis and development and miR-18b-5p might be a prognostic biomarker and potential therapeutic target for OS treatment.
Funder
the project of Huazhong University of Science and Technology Union Shenzhen Hospital
the project of Shenzhen Nanshan District Science and Technology
Science and Technology Plan of Nanshan District of Shenzhen City
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Gill, J. & Gorlick, R. Advancing therapy for osteosarcoma. Nat. Rev. Clin. Oncol. 18, 609–624 (2021).
2. Lilienthal, I. & Herold, N. Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: A review of current and future strategies. Int. J. Mol. Sci. 21, 6885 (2020).
3. Chou, A. J. & Gorlick, R. Chemotherapy resistance in osteosarcoma: Current challenges and future directions. Expert Rev. Anticancer Ther. 6, 1075–1085 (2006).
4. Kager, L., Tamamyan, G. & Bielack, S. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 13, 357–368 (2017).
5. Reinblatt, M., Pin, R. H., Federoff, H. J. & Fong, Y. Utilizing tumor hypoxia to enhance oncolytic viral therapy in colorectal metastases. Ann. Surg. 239(892–9), 899–902 (2004).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献